
Citation: Damian G. D'Souza. The Parathyroid Hormone Family of Ligands and Receptors[J]. AIMS Medical Science, 2015, 2(3): 118-130. doi: 10.3934/medsci.2015.3.118
[1] | Zairong Wang, Xuan Tang, Haohuai Liu, Lingxi Peng . Artificial immune intelligence-inspired dynamic real-time computer forensics model. Mathematical Biosciences and Engineering, 2020, 17(6): 7221-7233. doi: 10.3934/mbe.2020370 |
[2] | Yong-hong Hu, Xue-ying Wang, Xi-wen Zhang, Jian Chen, Fu Li . Investigation of the mechanisms and experimental verification of Shao yao gan cao decoction against Sphincter of Oddi Dysfunction via systems pharmacology. Mathematical Biosciences and Engineering, 2022, 19(12): 13374-13398. doi: 10.3934/mbe.2022626 |
[3] | Mingming Zhang, Huiyuan Jin, Ying Yang . ECG classification efficient modeling with artificial bee colony optimization data augmentation and attention mechanism. Mathematical Biosciences and Engineering, 2024, 21(3): 4626-4647. doi: 10.3934/mbe.2024203 |
[4] | Juan Palomares-Ruiz, Efrén Ruelas, Flavio Muñoz, José Castro, Angel Rodríguez . A fractional approach to 3D artery simulation under a regular pulse load. Mathematical Biosciences and Engineering, 2020, 17(3): 2516-2529. doi: 10.3934/mbe.2020138 |
[5] | Graciela Canziani, Rosana Ferrati, Claudia Marinelli, Federico Dukatz . Artificial neural networks and remote sensing in the analysis of the highly variable Pampean shallow lakes. Mathematical Biosciences and Engineering, 2008, 5(4): 691-711. doi: 10.3934/mbe.2008.5.691 |
[6] | Benjamin Steinberg, Yuqing Wang, Huaxiong Huang, Robert M. Miura . Spatial Buffering Mechanism: Mathematical Model and Computer Simulations. Mathematical Biosciences and Engineering, 2005, 2(4): 675-702. doi: 10.3934/mbe.2005.2.675 |
[7] | Javad Hassannataj Joloudari, Faezeh Azizi, Issa Nodehi, Mohammad Ali Nematollahi, Fateme Kamrannejhad, Edris Hassannatajjeloudari, Roohallah Alizadehsani, Sheikh Mohammed Shariful Islam . Developing a Deep Neural Network model for COVID-19 diagnosis based on CT scan images. Mathematical Biosciences and Engineering, 2023, 20(9): 16236-16258. doi: 10.3934/mbe.2023725 |
[8] | Marie Doumic, Sophie Hecht, Diane Peurichard . A purely mechanical model with asymmetric features for early morphogenesis of rod-shaped bacteria micro-colony. Mathematical Biosciences and Engineering, 2020, 17(6): 6873-6908. doi: 10.3934/mbe.2020356 |
[9] | Mehrdad Ahmadi Kamarposhti, Ilhami Colak, Kei Eguchi . Optimal energy management of distributed generation in micro-grids using artificial bee colony algorithm. Mathematical Biosciences and Engineering, 2021, 18(6): 7402-7418. doi: 10.3934/mbe.2021366 |
[10] | Yanxu Zhu, Hong Wen, Jinsong Wu, Runhui Zhao . Online data poisoning attack against edge AI paradigm for IoT-enabled smart city. Mathematical Biosciences and Engineering, 2023, 20(10): 17726-17746. doi: 10.3934/mbe.2023788 |
Severe urinary incontinence (SUI) is currently a widespread healthcare problem with millions of male patients worldwide [1], mostly aged over 50 years [2]. Male patients may undergo surgical treatment with Artificial Urinary Sphincter (AUS). This device ensures continence through occlusion of the urethral duct by means of a cuff generally placed in urethral bulbar region [3]. The most used AUS worldwide is the AMS 800 (Boston Scientific, Boston, USA) (Figure 1a). This prosthesis is based on an inflatable cuff (Figure 1b, c), a pressure-regulating balloon and a pump. Due to the surgical invasiveness of this device and a moderate rate of complications and revisions [3], new solutions have been developed in recent years. These devices are designed to simplify surgical procedures by decreasing the number of connecting parts and to allow the control of the cuff pressure in situ. Indeed, it is recognized that constant urethral pressure is probably causing urethral atrophy and erosion. Among new solutions, other devices present a similar structure and working principle to AMS 800. The ZSI 375 (Zephyr Surgical Implants, Geneva, Switzerland) (Figure 1d) is based on two parts connected by a tube and an adjustable cuff (Figure 1e, f) molded to fit around the urethra, a pressure-regulating reservoir and a pump. The pressure-regulating reservoir operates with a spring-controlled piston mechanism able to move a solution within the hydraulic circuit. The advantages of this device are related to low cost, adjustable cuff pressure and component size minimization. However, clinical trials did not highlight satisfactory results and the device has not been broadly implanted. Another alternative prosthesis is Tape Mechanical Occlusive Device TMOD (GT Urological, Minneapolis, MN, USA) [4], (Figure 1g), based on a spring-loaded mechanism able to move solution up to an occlusive cuff (Figure 1h, i), applying pressure around the urethra. Up to now, TMOD has been studied in a canine model and human cadavers, while clinical trials are in progress. More recent devices include Victo (Promedon, Córdoba, Argentina), which is based on the same working principle of AMS800, showing a modified cuff conformation (Figure 1l) [5,6], and Artus (MyoPowers Medical Technologies France SAS, Besançon, France), based on a smooth segmented silicon cuff that is individually actionable and adjustable with a remote control (Figure 1m). This device has already undergone first clinical studies [5,7] and seems promising due to a combination of new operational concept and optimized cuff design.
Nonetheless, at present AMS 800 remains to be considered the most safe and reliable treatment for stress UI [3,5,6,7,8,9,10], and is the most frequently used worldwide. Despite positive post-surgery outcomes, a relevant portion of patients requires revision surgery, due to complications including infection, urethral atrophy, erosion, and mechanical failure. These negative side effects are reported in clinical studies but are not investigated from a mechanical point of view. Considering its mechanical behavior, urethral duct is characterized by low stiffness and viscoelastic properties [11,12]. In order to occlude the urethra lumen against the bladder pressure, which can reach values of more than 40 cmH2O, a well-defined occluding action on the urethra has to be applied. The natural urethral sphincters are two muscles used to control the urine flow out of the bladder. These sphincters are able to guarantee continence for low bladder pressure and to exert a higher occlusive action to support the sudden increase of internal pressure, for example during cough, avoiding incontinence. In case of SUI, such occluding action can be produced by the AUS which must guarantee occlusion during all daily activities. Consequently, the occluding actions are usually elevated and protracted for a long period of time, determining a non-homogeneous strain field within urethral tissues. The value of strain may overcome 30% and can cause inflammation, atrophy and erosion phenomena. The specific occluding action that is required to close the urethra also depends on the AUS cuff structural conformation, as reported [13,14]. Actually, a successful treatment depends on the mechanical interaction between AUS cuff and urethral tissues.
AMS 800 cuff is chosen as reference in this work and is characterized by means of physicochemical and mechanical tests, addressed to the definition of a constitutive model of the cuff material. Several geometric configurations of the cuff, respectively deflated and inflated with pressures of 15, 30, and 50 cmH2O, are acquired by Computed Tomography (CT). This technique is increasingly used in geometrical metrology by non-destructive procedures to perform dimensional measurements with high accuracy and is capable for detailed three-dimensional geometrical models reconstruction [15,16,17,18,19,20]. CT data are assumed for the definition of the numerical model. The model is validated comparing CT images of the inflated cuff and the correspondent numerical results. This numerical model is applied for the investigation of urethral tissues response using AUS by a computational approach [14,21].
The experimental investigation was developed using a cuff provided by Boston Scientific. The sphincteric cuff is made up by a polymeric blister joined with a fiber-reinforced layer. To investigate these materials, morphological and physicochemical analyses were carried out. Preliminarily, the intact cuff was observed via optical microscopy (ZEISS Stemi 2000-C, Carl-Zeiss, Germany) with an Axio-Cam ERc5s photo camera, aiming at a definition of cuff conformation. Moreover, in order to evaluate cuff surface morphology, concerning both the polymer layer and the fiber-reinforced layer, samples were investigated by means of Environmental Scanning Electron Microscopy (E-SEM, FEI Quanta 200, FEI Company, USA). Energy-Dispersive X-ray Analysis (EDAX), also for an elemental analysis of the components, thus getting a primary evaluation of their chemical composition.
The cuff was cut in portions. Two samples (blister sample: 9 mm × 9 mm; cross section of fiber-reinforced layer: 1.5 mm × 9 mm) were analyzed by Fourier Transform Infrared Spectroscopy (FT-IR) by means of a NicoletTM iSTM 50 FT-IR Spectrometer with built-in ATR (Thermo Fisher ScientificTM).
The metrological CT system (Nikon X-Tek MCT225) equipped with a micro-focus X-ray source, a 16-bit detector with 2000 × 2000 pixels, and a high-precision manipulator is temperature-controlled (20 ± 0.5 ℃) and reaches acceleration voltages of 225 kV [22]. The AMS800 cuff was scanned at air pressures of 0, 15, 30, and 50 cmH2O to evaluate the mechanical response, considering the maximum value reached with the open fluid-filled cuff during experimental activities. The CT measurement procedure consisted of three main steps, as acquisition of bi-dimensional X-ray projections of the sample at homogeneously distributed angular positions between 0 and 360° (with angular step equal to 0.24°), three-dimensional reconstruction of a voxel-based geometrical model and surface determination [22]. To avoid the impact of gravity onto cuff’s shape, the sample was placed on a high precision rotary table after being oriented in vertical position using a support made of carbon fiber reinforced polymer, chosen according to low X-ray absorption. The parameters used for CT scanning are reported in Table 1. After the X-ray projections were collected, a 3D virtual solid model of the investigated cuff was reconstructed by means of a filtered back-projection algorithm [23]. The achieved voxel size was 37 μm. The surface determination procedure was performed using the software VGStudio MAX 3.1 (Volume Graphics GmbH, Germany), applying a local adaptive thresholding method in order to define the material boundaries with sub-voxel accuracy [24]. Local adaptive thresholding chooses threshold values for every pixel in the image based on an analysis of its neighboring pixels, as described in [24]. This procedure has been chosen with the final purpose to define a 3D model of AUS cuff.
Parameter | Value |
Voltage | 150 kV |
Current | 93 μA |
Power | 14 W |
Exposure time | 1000 ms |
Nr. of projections | 1500 |
Experimental tests on cuff materials and overall structure, as uniaxial tensile test on samples and overall cuff inflation test, were carried out to evaluate the actual mechanical behavior, as a basis for constitutive modeling. Material mechanical characterization was carried out by a Bose Electro-Force Planar Biaxial Test Bench Instrument, under displacement control with a precision of 0.001 mm and using a load cell with a precision of 0.02 N [11]. Rectangular pieces 3 × 9 mm were cut from the cuff. Their mean width was determined from five independent measurements each. Sample thickness was identified from CT images of the cuff region where each sample was cut. Each test was repeated on three samples, by imposing elongation up to 35% strain, which is the maximum strain value measured in CT images when the cuff is inflated at high pressure. For each experimental test, nominal stress (σ) together with nominal strain (ε) were measured and, for each group of test repetitions, the mean values and standard deviations (SD) were calculated.
The structural behavior of the cuff was analyzed by inflation tests [11,12,25,26,27,28] and used for the validation procedure. Details about the inflation protocol are reported as follows [14,21]. Sample experimenting was performed by continuous inflation of saline (0.9% NaCl, room temperature) at 0.5 mL/s inflation rate [21] up to full filling of the cuff, which was achieved at 4 mL. The overall inflation test was repeated three times.
Data from CT was subsequently elaborated by 3D CAD software (UGS NX 6; Siemens PLM Software, Munich, Germany) to define a virtual solid model. The solid model was discretized into the finite element pre-processing software Abaqus/CAE 6.14 [29]. Different models were developed assuming incremental mesh refinement using 4-node tetrahedral elements. Numerical analyses were performed comparing the results, aiming at a sensitivity analysis with regard to mesh conformation. The final configuration was of about three hundred thousand degrees of freedom providing a numerical model capable of interpreting the mechanical behavior with suitable accuracy and minor computational cost. For the polymeric blister, considering the results from the tensile tests, an isotropic hyperelastic formulation [30] was assumed:
$W\left( {\bf{C}} \right) = {C_1}\left( {{{\tilde I}_1} - 3} \right) + {K_v}{\left( {J - 1} \right)^2}$ | (1) |
where ${\bf{C}}$ is the right Cauchy-Green strain tensor, ${\tilde I_1}$ is the first iso-volumetric invariant of ${\bf{C}}$, as ${\tilde I_1} = {\rm tr}\left({{J^{{{ - 2} \mathord{\left/ {\vphantom {{ - 2} 3}} \right. } 3}}}{\bf{C}}} \right)$ and J is the deformation Jacobian, as $J = \sqrt {\det\left({\bf{C}} \right)} $. The volumetric stiffness is related to the constitutive parameter ${K_v}$, as $B = 2{K_v}$, while shear stiffness is defined as $G = 2{C_1}$ [30].
The mechanical behavior of the reinforced layer was defined using a fiber-reinforced hyperelastic model based on the contributions of two fibers families along the principal directions of the reinforcing mesh. The following general formulation of the strain energy, divided in the isotropic matrix (Wm) and the fibers (Wf) [31,32,33] contributions, was defined:
$W\left( {\bf{C}} \right) = W_m^{}\left( {\bf{C}} \right) + W_{{f_i}}^{}\left( {{\bf{C}}, {{\bf{a}}_0}^i \otimes {{\bf{a}}_0}^i} \right)$ | (2) |
${W_m}\left( {\bf{C}} \right) = {C_1}\left( {{{\tilde I}_1} - 3} \right) + {K_v}{\left( {J - 1} \right)^2}$ | (3) |
$W_{{f_i}}^{}\left( {{\bf{C}}, {{\bf{a}}_0}^i \otimes {{\bf{a}}_0}^i} \right) = \left[ {{{{C_4}^i} \mathord{\left/ {\vphantom {{{C_4}^i} {{{\left( {{\alpha _4}^i} \right)}^2}}}} \right. } {{{\left( {{\alpha _4}^i} \right)}^2}}}} \right]\left\{ {\exp \left[ {{\alpha _4}^i\left( {{I_4}^i - 1} \right)} \right] - {\alpha _4}^i\left( {{I_4}^i - 1} \right) - 1} \right\}$ | (4) |
where ${{\bf{a}}_0}^i$ are the fibers direction, resulting from morphological characterization. The structural invariant ${I_4}^i$ is defined as ${I_4}^i = {\bf{C}}:\left({{{\bf{a}}_0}^i \otimes {{\bf{a}}_0}^i} \right)$, while the constitutive parameters ${C_4}^i$ and ${\alpha _4}^i$ describes the ith fibers family initial stiffness and the increase of fibers stiffness with stretch, respectively.
The discrepancy between model results and experimental data from tensile tests was evaluated by a cost function [33], whose minimization was performed by a stochastic-deterministic procedure [28,31,32]. The constitutive parameters identified were the same for the isotropic contribution of the polymeric blister and the reinforced layer (Table 2).
Kv | C1 | C4 | α4 | Cost Function | |
polymeric blister | 8.920 MPa | 0.361 MPa | - | - | 0.013 |
reinforced layer | 8.920 MPa | 0.361 MPa | 6.470 MPa | 1.520 | 0.020 |
Numerical analysis has been developed to simulate the inflation tests in order to validate the model developed by comparison with experimental data. A fluid-filled cavity was defined by the cuff inner surface [14,21]. Inflation process was simulated by defining a flow rate corresponding to the experimental condition. Numerical computation was performed by a HPC server equipped with two Intel Xeon E7 8890 v4 and 256 GB RAM. The analysis was developed by using 4 cpus and lasted about two hours.
During surgery, the blister of AUS cuff is positioned in contact with urethral tissues when the cuff is wrapped around the duct, while the fiber-reinforced layer is kept outwardly. The fiber-reinforced layer is based on mesh embedded in a polymeric matrix, as shown in Figure 2a. SEM analysis was carried out on the polymeric blister and on the fiber-reinforced layer. The transversal section of the fiber-reinforced layer was also observed, to get an insight on the reinforcing mesh material and conformation. The outer surface of the polymeric blister is smooth and homogeneous, while the outer surface of the fiber-reinforced layer is slightly rougher. A detail of the fiber conformation (Figure 2b, c) shows the multifilament structure of the fiber, composed by filaments with a diameter of about 30 μm. EDAX analysis was carried out to get qualitative data on the elemental composition of the blister and fibers as shown in Figure 2d. The EDAX spectrum on the blister revealed chemical elements that are ascribable to polydimethylsiloxane (PDMS), in accordance with data reported in AMS800 technical datasheet. Differently, EDAX analysis of the fiber showed the presence of oxygen and carbon, as for several polymeric materials. Further chemical analysis was performed for a more accurate identification. Indeed, the analysis of the physicochemical properties was enhanced through FT-IR, to highlight the constituent materials. FT-IR spectra, shown in Figure 2e, confirmed that the main polymeric materials used in cuff manufacturing is PDMS [34,35,36]. The FT-IR spectrum of a fiber presented the main characteristic bands of polyethylene terephthalate (PET) [37,38,39]. This analysis provides additional data which are not commonly reported in AMS800 technical datasheet.
CT scan provided an accurate three-dimensional geometrical model of the cuff in the deflated configuration (Figure 3a), as well as specific dimensional measurements. The software VGStudio MAX was used for the evaluation of wall-thickness and internal distance between surfaces. The wall thickness at selected sections were reported in (Figure 3b).
Results of tensile tests were reported for the cuff at the fiber-reinforced layer (Figure 4a) and the polymeric blister (Figure 4b). The fiber-reinforced layer exhibited a nonlinear mechanical behavior, with an increasing stiffness that is correlated with the reinforcement of PET network within the PDMS ground matrix. Differently, the blister was characterized by a continuous non-linear mechanical response, with much lower stiffness. The mechanical characteristics for silicone materials can vary considerably and a sensitivity analysis was performed to investigate the effects of its variation on the overall cuff response, also considering fibers contribute. The values assumed on the specific case considered, reported by means of the constitutive material parameters, depend on average data form mechanical test associated with data in literature, but keeping in mind that the most relevant aspect, from structural point of view, is related to the geometric conformation, that was deeply investigated by CT imaging and accurately reported.
The numerical model of the cuff, obtained by the virtual solid model, was reported (Figure 5). Inflation experimental activities led to pressure data, related to the volume imposed history. The distribution of pressure vs volume data and numerical results were compared (Figure 6a), showing a valid agreement. The maximum pressure condition was 50 cmH2O. The contour of the displacement magnitude of the cuff was reported for the pressures of 15, 30 and 50 cmH2O (Figure 6b). The validation of the numerical model was obtained also comparing the numerical results with the data obtained by CT scan at selected pressures (Figure 7). The internal distance between surfaces and the conformation of the cuff in the numerical model was compared by the CT scan data, at the intersection named as D-D, E-E, F-F (Figure 7) reported on section A-A (Figure 3), at 15, 30 and 50 cmH2O. The discrepancies between the CT data and model results were reported in terms of percentage error. At section D-D the error was less than 2% while at sections E-E and F-F the error was of the order of 2.5%. The good agreement between data from experimental tests and numerical results proved the reliable interpretation of the mechanical response of the cuff.
In this work, the experimental and computational approaches are combined to develop a finite element model of AUS cuff, aiming at providing tools for the in vitro and in silico investigation of AUS reliability during the interaction between prosthesis and urethra. The adopted procedure consists in subsequent steps including material and geometric characterization of the cuff (Figures 2-4), definition of a solid and numerical model (Figure 5) and validation by comparison of numerical results with CT images of inflated cuff (Figures 5 and 6).
The definition of the constitutive formulation developed is essential for the numerical analysis and is performed in the light of the specific experience in this area [14,25,31,33]. Results from physicochemical and mechanical testing represent a reference term for constitutive modeling. However, a limitation of this study is related to the experimental data acquired by mechanical tests, which do not take into account time-dependent behavior. Finite element discretization of the cuff that is assumed in the light of a sensitivity analysis, considering the best compromise between reducing computational cost and increasing accuracy. Model validation is achieved comparing the measurements provided by CT scanning of AUS cuff inflated at selected pressure levels and the corresponding numerical results. This approach enables to obtain a reliable numerical model able to interpret AUS cuff mechanics for in silico trials.
The approach can be applied to further artificial sphincters on the market and under development. For example, severe fecal incontinence is generally treated by the implantation of an artificial sphincter composed of a fluid-filled cuff [41]. As for the AMS800 cuff, the geometrical and mechanical parameters are crucial and can be characterized by in silico analysis.
This work is part of extended research activities addressed to biomechanical analysis of prosthetic devices for urinary incontinence. In the frame of this topic, the urethral tissues were characterized with comprehensive experimental activities and numerical modelling [12,26,28]. To consider ageing and pathological conditions, a specific investigation has been carried out evaluating different urethral tissue conditions, in accordance with variable stiffness [40,42].
The interaction between urethra and AUS cuff has been studied by means of computational analysis to identify the AUS pressure that ensures lumen occlusion and the stress distributions within biological tissues [14,21]. This investigation entails a detailed knowledge of AUS conformation and mechanics achieved through experimental characterization and numerical modelling, as here presented. In this work, only AMS 800 is considered, but also other AUS devices can be studied with the same approach. Moreover, nevertheless the main application of AUS devices pertain to adulty male subjects, the investigation of AUS can be extended to other patients, considering the number of females and children that have obtained AUS [43,44]. Despite some limitations, this study offers a valid basis for the comprehension of AUS cuff behavior and the development of computational analysis of AUS cuff associated to urethral duct.
This study has been supported by University of Padova, Project n℃PDA148900/14, titled COMPUR: Definition of COMPutational tools for the analysis of the biomechanical functionality of the lower URinary system.
The authors declare no conflict of interest in this paper.
[1] | Gardella TJ, Juppner H (2001) Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol Metab 12(5): p. 210-217. |
[2] | Gensure RC, Gardella TJ, Juppner H (2005) Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328(3): p. 666-678. |
[3] | Guerreiro PM, Renfro JL, DM Power, et al. (2007) The parathyroid hormone family of peptides: structure, tissue distribution, regulation, and potential functional roles in calcium and phosphate balance in fish. Am J Physiol Regul Integr Comp Physiol 292(2): p. R679-696. |
[4] | Jerome CP, DB Burr, Bibber TV, et al. (2001) Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28(2): p. 150-159. |
[5] | Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423(6937): p. 332-336. |
[6] | Philbrick WM, Wysolmerski J J, Galbraith S, et al. (1996) Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76(1): p. 127-173. |
[7] | On JS, Chow BK, Lee LT (2015) Evolution of parathyroid hormone receptor family and their ligands in vertebrate. Front Endocrinol (Lausanne) 6: p. 28. |
[8] | John MR, Arai M, Rubin DA, et al. (2002) Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues. Endocrin 143(3): p. 1047-1057. |
[9] | Papasani MR, Robert CG, John HB, et al. (2004) Identification and characterization of the zebrafish and fugu genes encoding tuberoinfundibular peptide 39. Endocrin 145(11): p. 5294-5304. |
[10] | Gensure RC, Cooper WC, Nickols GA, et al. (2004) Identification and characterization of two parathyroid hormone-like molecules in zebrafish. Endocrin 145(4): p. 1634-9. |
[11] | Shoemaker JM, Riley LG, Hirano T, et al. (2005) Differential expression of tuberoinfundibular peptide 38 and glucose-6-phosphatase in tilapia. Gen Comp Endocrinol 146(2): p. 186-94. |
[12] | Bhattacharya P, Yan Y-L, David AR, et al. (2001) Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development. J Endocrinol 211(2): p. 187-200. |
[13] | Brommage R, Lees CG, Hotchkiss CE, et al. (1999) Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84(10): p. 3757-3763. |
[14] | Brown EM (1999) Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 106(2): p. 238-253. |
[15] | Gunther T, Chen ZF, Kim G, et al. (2000) Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406(6792): p. 199-203. |
[16] | Tucci J, Russell A, Senior SV, et al. (1996) The expression of parathyroid hormone and parathyroid hormone-related protein in developing rat parathyroid glands. J Mol Endocrinol 17(2): p. 149-157. |
[17] | Harvey S, Hayer S, Sloley BD (1993) Dopaminergic actions of parathyroid hormone in the rat medial basal hypothalamus in vitro. Regul Pept 43(1-2): p. 49-56. |
[18] | Henriksen K, Neutzsky-Wulff AV, Bonewald LF, et al. (2009) Local communication on and within bone controls bone remodeling. Bone 44(6): p. 1026-1033. |
[19] | Hayden RS, Fortin JP, Harwood B, et al. (2014) Cell-tethered ligands modulate bone remodeling by osteoblasts and osteoclasts. Adv Funct Mater 24(4): p. 472-479. |
[20] | Sims NA, Vrahnas C (2014) Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts. Arch Biochem Biophys 561: p. 22-28. |
[21] | Chen H, Senda T, Kubo KY (2015) The osteocyte plays multiple roles in bone remodeling and mineral homeostasis. Med Mol Morphol 48(2): p. 61-68. |
[22] | Danks JA, Damian GD, Gunn HJ, et al. (2011) Evolution of the parathyroid hormone family and skeletal formation pathways. Gen Comp Endocrinol 170(1): p. 79-91. |
[23] | Han SW, Kim SJ, Lee DJ, et al. (2014) The Relationship between Serum 25-Hydroxyvitamin D, Parathyroid Hormone and the Glomerular Filtration Rate in Korean Adults: The Korea National Health and Nutrition Examination Survey between 2009 and 2011. Korean J Fam Med 35(2): p. 98-106. |
[24] | Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. Jama 294(18): p. 2336-2341. |
[25] | Stewart AF, Horst R, Deftos LJ, et al. (1980) Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303(24): p. 1377-1383. |
[26] | de la Mata J, Mundy GR, Guise TA, et al. (1995) Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95(6): p. 2846-2852. |
[27] | Schipani E, Provot S (2003) PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. Birth Defects Res C Embryo Today 69(4): p. 352-362. |
[28] | Lanske B, Pajevic PD, Kovacs CS, et al. (1998) The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrin 139(12): p. 5194-5204. |
[29] | Karaplis AC, Kronenberg HM, Mulligan RC, et al. (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8(3): p. 277-289. |
[30] | Ongkeko WM, Burton D, Kiang A, et al. (2014) Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer. PLoS One 9(1): p. e85803. |
[31] | Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6): p. 442-454. |
[32] | Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28(1-2): p. 15-33. |
[33] | McCauley LK, Martin TJ (2012) Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res 27(6): p. 1231-1239. |
[34] | Agouni A, Sourbier C, Danilin S, et al. (2007) Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B. Carcinogenesis 28(9): p. 1893-1901. |
[35] | Clemens TL, Cormier S, Eichinger A, et al. (2001) Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol 134(6): p. 1113-1136. |
[36] | Goomer RS, Shen X, Falzon M, et al. (2000) The tetrabasic KKKK(147-150) motif determines intracrine regulatory effects of PthrP 1-173 on chondrocyte PPi metabolism and matrix synthesis. Endocrin 141(12): p. 4613-4622. |
[37] | Watson PH, Hodsman AB, Fraher LJ, et al. (2000) Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J Bone Miner Res 15(6): p. 1033-1044. |
[38] | Juppner H, Kronenberg HM, Segre GV, et al. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254(5034): p. 1024-1026. |
[39] | Pilz P, Meyer-Marcotty P, Eigenthaler M, et al. (2014) Differential diagnosis of primary failure of eruption (PFE) with and without evidence of pathogenic mutations in the PTHR1 gene. J Orofac Orthop 75(3): p. 226-239. |
[40] | Piserchio A, Usdin T, Mierke DF (2000) Structure of tuberoinfundibular peptide of 39 residues. J Biol Chem 275(35): p. 27284-27290. |
[41] | Jonsson KB, John MR, Gensure R, et al. (2001) Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist. Endocrin 142(2): p. 704-709. |
[42] | Gardella TJ, et al. (1996) Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist. J Biol Chem 271(33): p. 19888-93. |
[43] | Tenne M, McGuigan F, Jansson L, et al. (2008) Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone 42(4): p. 719-727. |
[44] | Usdin TB, Gruber C, Bonner TI (1995) Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270(26): p. 15455-15458. |
[45] | Usdin TB, Hoare SR, Wang T, et al. (1999) TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 2(11): p. 941-943. |
[46] | Usdin TB (1997) Evidence for a parathyroid hormone-2 receptor selective ligand in the hypothalamus. Endocrin 138(2): p. 831-834. |
[47] | Usdin TB, Modi W, Bonner TI (1996) Assignment of the human PTH2 receptor gene (PTHR2) to chromosome 2q33 by fluorescence in situ hybridization. Genomics 37(1): p. 140-141. |
[48] | Gardella TJ, Vilardaga JP (2015) International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors. Pharmacol Rev 67(2): p. 310-337. |
[49] | Dobolyi A, Palkovits M, Usdin TB (2003) Expression and distribution of tuberoinfundibular peptide of 39 residues in the rat central nervous system. J Comp Neurol 455(4): p. 547-566. |
[50] | Dobolyi A, Dimitiov E, Palkovits M, et al. (2012) The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol (Lausanne) 3: p. 121. |
[51] | Hoare SR, Rubin DA, Jüppner H, et al. (2000) Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues. Endocrin 141(9): p. 3080-3086. |
[52] | Eichinger A (2002) Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels. Endocrin 143(8): p. 3036-3043. |
[53] | Pinheiro PL, Cardoso JCR, Power DM, et al. (2012) Functional characterization and evolution of PTH/PTHrP receptors: insights from the chicken. BMC Evol Biol 12: p. 110. |
[54] | Rubin DA, Juppner H (1999) Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem 274(40): p. 28185-28190. |
[55] | Rubin DA, Hellman P, Zon LI, et al. (1999) A G protein-coupled receptor from zebrafish is activated by human parathyroid hormone and not by human or teleost parathyroid hormone-related peptide. Implications for the evolutionary conservation of calcium-regulating peptide hormones. J Biol Chem 274(33): p. 23035-23042. |
[56] | Rotllant J, Redruello B, Power DM, et al. (2006) Ligand binding and signalling pathways of PTH receptors in sea bream (Sparus auratus) enterocytes. Cell Tissue Res 323(2): p. 333-341. |
[57] | Pinheiro PL, Gomes AS, Power DM, et al. (2010) Gene structure, transcripts and calciotropic effects of the PTH family of peptides in Xenopus and chicken. BMC Evol Biol 10: p. 373. |
[58] | Canario AV, Rotllant J, Power DM, et al. (2006) Novel bioactive parathyroid hormone and related peptides in teleost fish. FEBS Lett 580(1): p. 291-299. |
[59] | Cardoso JC, Felix RC, Power DM (2014) Nematode and arthropod genomes provide new insights into the evolution of class 2 B1 GPCRs. PLoS One 9(3): p. e92220. |
[60] | D'Souza DG, Rana K, Milley KM, et al. (2013) Expression of Wnt signaling skeletal development genes in the cartilaginous fish, elephant shark (Callorhinchus milii). Gen Comp Endocrin 193: p. 1-9. |
[61] | Hwang JI, Moon MJ, Park M, et al. (2013) Expansion of secretin-like G protein-coupled receptors and their peptide ligands via local duplications before and after two rounds of whole-genome duplication. Mol Biol Evo 30(5): p. 1119-1130. |
[62] | On JS, Duan C, Chow BK, et al. (2015) Functional Pairing of Class B1 Ligand-GPCR in Cephalochordate Provides Evidence of the Origin of PTH and PACAP/Glucagon Receptor Family. Mol Biol Evol |
[63] | Cardoso JC, Pinto1 VC, Vieira1 FA, et al. (2006) Evolution of secretin family GPCR members in the metazoa. BMC Evol Biol 6: p. 108. |
[64] | Mirabeau O, Joly JS (2013) Molecular evolution of peptidergic signaling systems in bilaterians. Proc Natl Acad Sci USA 110(22): p. E2028-2037. |
[65] | Liu Y, Ibrahim AS, Walker TI, et al. (2010) Parathyroid hormone gene family in a cartilaginous fish, the elephant shark (Callorhinchus milii). J Bone Miner Res 25(12): p. 2613-2623. |
[66] | Ingleton PM (2002) Parathyroid hormone-related protein in lower vertebrates. Comp Biochem Physiol B Biochem Mol Biol 132(1): p. 87-95. |
[67] | Ingleton PM, Danks JA (1996) Distribution and functions of parathyroid hormone-related protein in vertebrate cells. Int Rev Cytol 166: p. 231-280. |
[68] | Abbink W, Flik G (2007) Parathyroid hormone-related protein in teleost fish. Gen Comp Endocrinol 152(2-3): p. 243-251. |
[69] | Barden JA, Cuthbertson RM (1993) Stabilized NMR structure of human parathyroid hormone(1-34). Eur J Biochem 215(2): p. 315-321. |
[70] | Ray FR, Barden JA, Kemp BE (1993) NMR solution structure of the [Ala26] parathyroid-hormone-related protein(1-34) expressed in humoral hypercalcemia of malignancy. Eur J Biochem 211(1-2): p. 205-211. |
[71] | Shimizu N, Petroni BD, Khatri A, et al. (2003) Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues. Biochem 42(8): p. 2282-2290. |
[72] | Blind E, Raue F, Knappe F, et al. (1993) Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34. Exp Clin Endocrinol 101(3): p. 150-155. |
[73] | Neer RM, Arnaud CD, Zanchetta JR, et al. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19): p. 1434-1441. |
[74] | Nutt RF, Caulfield MP, Levy JJ, et al. (1990) Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11. Endocrin 127(1): p. 491-493. |
[75] | Carter PH, Dean T, Gardella TJ, et al. (2015) Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor. Mol Endocrinol. 29(2): p. 307-321. |
[76] | Mann R, Wigglesworth MJ, Donnelly D (2008) Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor. Mol Pharmacol 74(3): p. 605-613. |
[77] | Pioszak AA, Xu HE (2008) Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 105(13): p. 5034-5039. |
[78] | Barbier JR, MacLean S, Whitfield JF, et al. (2001) Structural requirements for conserved arginine of parathyroid hormone. Biochemistry 40(30): p. 8955-8961. |
[79] | Dean T, Khatri A, Gardella TJ, et al. (2006) Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor. J Biol Chem 281(43): p. 32485-32495. |
[80] | Weaver RE, Wigglesworth MJ, Donnelly D (2014) A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity. Peptides 61: p. 83-87. |
[81] | Pizurki L, Rizzoli R, Bonjour JP (1990) Inhibition by (D-Trp12,Tyr34)bPTH(7-34)amide of PTH and PTHrP effects on Pi transport in renal cells. Am J Physiol 259(2 Pt 2): p. F389-392. |
[82] | Carter PH, Juppner H, Gardella TJ (1999) Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents. Endocrin 140(11): p. 4972-4981. |
[83] | Cohen FE, Strewler GJ, Bradley MS, et al. (1991) Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J Biol Chem 266(3): p. 1997-2004. |
[84] | Whitfield JF, Morley P (1995) Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis. Trends Pharmacol Sci 16(11): p. 382-386. |
[85] | Whitfield JF, Bringhurst FR (2000) Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2. J Bone Miner Res 15(5): p. 964-970. |
[86] | Luck MD, Carter PH, Gardella TJ (1999) The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Mol Endocrinol 13(5): p. 670-680. |
[87] | Shimizu M, Potts JT, Gardella TJ, et al. (2000) Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem 275(29): p. 21836-21843. |
[88] | Liu Y, Cai Y, Liu W, et al. (2015) Triblock peptide-linker-lipid molecular design improves potency of peptide ligands targeting family B G protein-coupled receptors. Chem Commun (Camb) 51(28): p. 6157-6160. |
[89] | Neer M, Slovik DM, DalyM, et al. (1993) Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3 Suppl 1: p. 204-205. |
[90] | Reeve J, Hesp R, Williams D, et al. (1976) Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1(7968): p. 1035-1038. |
[91] | Divieti P, Geller AI, Suliman G, et al. (2005) Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrin 146(4): p. 1863-1870. |
[92] | Inomata N, Akiyama M, Kubota N, et al. (1995) Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84). Endocrin 136(11): p. 4732-4740. |
[93] | Venkatesh B, Lee AP, Ravi V, et al. (2014) Elephant shark genome provides unique insights into gnathostome evolution. Nature 505(7482): p. 174-179. |
1. | Jitendra Singh Rathore, Prateek Saxena, Non-destructive quality assessment of bio-engineering parts using Industrial Micro X-ray Computed Tomography: A review, 2021, 287, 0167577X, 129252, 10.1016/j.matlet.2020.129252 | |
2. | Maria Vittoria Mascolini, Emanuele Luigi Carniel, In silico assessment of the reliability and performance of artificial sphincter for urinary incontinence, 2024, 48, 0160-564X, 1112, 10.1111/aor.14805 | |
3. | Kevin Krughoff, Jordan R. Foreman, Andrew C. Peterson, Characterizing and Quantifying Material Fatigue of the Artificial Urinary Sphincter Pressure Regulating Balloon, 2024, 183, 00904295, 244, 10.1016/j.urology.2023.10.008 | |
4. | Gianluca Mazzucco, Paola Pirini, Chiara Giulia Fontanella, Alice Berardo, Maria Vittoria Mascolini, Ilaria Toniolo, Leonardo Marziale, Tommaso Mazzocchi, Gioia Lucarini, Nicolò Spiezia, Emanuele Luigi Carniel, In silico tools for mechanical analysis of extra‐ and intra‐luminal artificial urinary sphincters, 2024, 2688-4526, 10.1002/bco2.473 | |
5. | A. A. Tomilov, E. I. Veliev, E. N. Golubtsova, Z. A. Bagatelia, Revision of the artificial urinary sphincter in men: a long-term experience from a single centre, 2025, 13, 2308-6424, 56, 10.21886/2308-6424-2025-13-1-56-62 |
Parameter | Value |
Voltage | 150 kV |
Current | 93 μA |
Power | 14 W |
Exposure time | 1000 ms |
Nr. of projections | 1500 |
Kv | C1 | C4 | α4 | Cost Function | |
polymeric blister | 8.920 MPa | 0.361 MPa | - | - | 0.013 |
reinforced layer | 8.920 MPa | 0.361 MPa | 6.470 MPa | 1.520 | 0.020 |